Aug 21, 2018   SOURCE: PR NewsWire

The Global Disposable IV Products Market 2018-2022 - Key Vendors Covered are 3M, Baxter, BD, Fresenius, ICU Medical, and Smiths Group

DUBLIN, Aug. 21, 2018 /PRNewswire/ --

The "Global Disposable IV Products Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The Global Disposable IV Products Market is forecast to grow at a CAGR of 6.52% during the period 2018-2022.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend affecting this market is the growing adoption of home healthcare users. Home IV solution therapy is becoming increasingly popular among patients globally. The increase in the aging population promotes the use of disposable products since IV infusion enable patients to be discharged from the hospitals early and recuperate in their homes using home IV infusions.

According to the report, one driver influencing this market is the rising occurrence of chronic diseases. Chronic diseases such as cancer, diabetes, and CVDs have significantly increased owing to factors such as the increase in urbanization, sedentary lifestyles, and an unbalanced diet.

Further, the report states that one challenge affecting this market is the side effects of IV therapy. The IV therapy is associated with side effects and complications such as phlebitis, an inflammation of the veins, which can result in other side effects for patients.

Key Vendors

    --  3M
    --  Baxter
    --  BD
    --  Fresenius
    --  ICU Medical
    --  Smiths Group

Key Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

    --  Market ecosystem
    --  Market characteristics
    --  Market segmentation analysis

PART 05: MARKET SIZING

    --  Market definition
    --  Market sizing 2017
    --  Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

    --  Bargaining power of buyers
    --  Bargaining power of suppliers
    --  Threat of new entrants
    --  Threat of substitutes
    --  Threat of rivalry
    --  Market condition

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY END-USER

    --  Segmentation by end-user
    --  Comparison by end-user
    --  Hospitals - Market size and forecast 2017-2022
    --  Home healthcare - Market size and forecast 2017-2022
    --  Others - Market size and forecast 2017-2022
    --  Market opportunity by end-user

PART 09: REGIONAL LANDSCAPE

    --  Geographical segmentation
    --  Regional comparison
    --  Americas - Market size and forecast 2017-2022
    --  EMEA - Market size and forecast 2017-2022
    --  APAC - Market size and forecast 2017-2022
    --  Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

    --  Market drivers
    --  Market challenges

PART 12: MARKET TRENDS

    --  Growing adoption by home healthcare users
    --  Increased demand for vitamin and iron infusions
    --  Rise in M&A

PART 13: VENDOR LANDSCAPE

    --  Overview
    --  Landscape disruption

PART 14: VENDOR ANALYSIS

    --  Vendors covered
    --  Vendor classification
    --  Market positioning of vendors
    --  3M
    --  Baxter
    --  BD
    --  Fresenius
    --  ICU Medical
    --  Smiths Group

For more information about this report visit https://www.researchandmarkets.com/research/z5cr56/the_global?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content with multimedia:http://www.prnewswire.com/news-releases/the-global-disposable-iv-products-market-2018-2022---key-vendors-covered-are-3m-baxter-bd-fresenius-icu-medical-and-smiths-group-300699588.html

SOURCE Research and Markets